JP2012526726A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526726A5 JP2012526726A5 JP2011548484A JP2011548484A JP2012526726A5 JP 2012526726 A5 JP2012526726 A5 JP 2012526726A5 JP 2011548484 A JP2011548484 A JP 2011548484A JP 2011548484 A JP2011548484 A JP 2011548484A JP 2012526726 A5 JP2012526726 A5 JP 2012526726A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- therapeutic agent
- pharmaceutical formulation
- present
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims description 117
- 239000003814 drug Substances 0.000 claims description 107
- 229940124597 therapeutic agent Drugs 0.000 claims description 107
- 239000000203 mixture Substances 0.000 claims description 61
- 150000003839 salts Chemical group 0.000 claims description 57
- 241000288906 Primates Species 0.000 claims description 41
- 239000012458 free base Substances 0.000 claims description 26
- 239000001913 cellulose Substances 0.000 claims description 21
- 229920002678 cellulose Polymers 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 16
- 150000004676 glycans Chemical class 0.000 claims description 15
- 229920001282 polysaccharide Polymers 0.000 claims description 15
- 239000005017 polysaccharide Substances 0.000 claims description 15
- 238000009472 formulation Methods 0.000 claims description 13
- HGASFNYMVGEKTF-UHFFFAOYSA-N octan-1-ol;hydrate Chemical compound O.CCCCCCCCO HGASFNYMVGEKTF-UHFFFAOYSA-N 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 10
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 235000019640 taste Nutrition 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920000945 Amylopectin Polymers 0.000 claims description 2
- 229920000856 Amylose Polymers 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000002535 acidifier Substances 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 239000000227 bioadhesive Substances 0.000 claims description 2
- 235000019658 bitter taste Nutrition 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims description 2
- 239000008139 complexing agent Substances 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 150000004677 hydrates Chemical class 0.000 claims description 2
- 239000001341 hydroxy propyl starch Substances 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- 239000000832 lactitol Substances 0.000 claims description 2
- 235000010448 lactitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 2
- 229960003451 lactitol Drugs 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 229920002521 macromolecule Polymers 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 13
- 230000001225 therapeutic effect Effects 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17890009P | 2009-05-15 | 2009-05-15 | |
| US61/178,900 | 2009-05-15 | ||
| PCT/JP2010/003285 WO2010131486A1 (en) | 2009-05-15 | 2010-05-14 | Intranasal pharmaceutical compositions with improved pharmacokinetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012526726A JP2012526726A (ja) | 2012-11-01 |
| JP2012526726A5 true JP2012526726A5 (cg-RX-API-DMAC7.html) | 2013-06-27 |
Family
ID=43084869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011548484A Pending JP2012526726A (ja) | 2009-05-15 | 2010-05-14 | 薬物動態が改善された鼻腔内用薬学的組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9101539B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2429495A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012526726A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010131486A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9701737B2 (en) | 2003-02-19 | 2017-07-11 | Camas, Incorporated | Immunogen adherence and method of making and using same |
| WO2004073729A1 (ja) * | 2003-02-21 | 2004-09-02 | Translational Research Ltd. | 薬物の経鼻投与用組成物 |
| US7278982B2 (en) | 2003-03-27 | 2007-10-09 | Bioactis Limited | Powder medicine applicator for nasal cavity |
| EP1785145A4 (en) | 2004-08-10 | 2008-08-13 | Translational Res Ltd | TRANSNASAL COMPOSITION WITH IMMEDIATE EFFECT AND HIGH RESORBIBILITY |
| GB0503738D0 (en) * | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
| JP5415769B2 (ja) | 2006-12-26 | 2014-02-12 | 株式会社新日本科学 | 経鼻投与用製剤 |
| EP3272379A1 (en) | 2008-02-07 | 2018-01-24 | The University of Washington | Circumferential aerosol device |
| WO2011013003A2 (en) * | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
| CA2796593C (en) * | 2010-04-15 | 2020-12-15 | Shin Nippon Biomedical Laboratories, Ltd. | Methods and compositions for intranasal delivery |
| BR112012028315A2 (pt) * | 2010-05-07 | 2016-10-25 | Camas Inc | "composição, borrifo oral, borrifo nasal, tira oral, enxaguatório bucal, e, método para prevenir ou reduzir a incidência de doença". |
| EP3679971B1 (en) | 2011-03-03 | 2022-07-27 | Impel Pharmaceuticals Inc. | Nasal drug delivery device |
| JP6645735B2 (ja) | 2011-05-09 | 2020-02-14 | インペル ニューロファーマ インコーポレイテッド | 鼻薬送達用ノズル |
| CN107049997A (zh) | 2011-12-21 | 2017-08-18 | 明治制果药业株式会社 | 局部给药型的吞咽障碍改善用药物 |
| ES2938466T3 (es) * | 2012-01-25 | 2023-04-11 | Chiesi Farm Spa | Formulación en polvo seco que comprende un corticoesteroide y un beta-adrenérgico para administración por inhalación |
| ES2634993T3 (es) * | 2012-03-30 | 2017-10-02 | Nuformix Limited | Composiciones y cocristales de tranilast |
| US9789071B2 (en) | 2012-06-27 | 2017-10-17 | G2B Pharma, Inc. | Intranasal formulation of epinephrine for the treatment of anaphylaxis |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| RS60481B1 (sr) | 2013-03-04 | 2020-08-31 | Besins Healthcare Lu Sarl | Suve farmaceutske kompozicije koje sadrže nanočestice aktivnog sredstva vezane za čestice nosača |
| WO2014179228A1 (en) | 2013-04-28 | 2014-11-06 | Impel Neuropharma Inc. | Medical unit dose container |
| HK1218855A1 (zh) | 2013-04-30 | 2017-03-17 | Otitopic Inc. | 干粉製劑及使用方法 |
| US9974768B2 (en) | 2013-06-13 | 2018-05-22 | Meiji Seika Pharma Co., Ltd. | Pharmaceutical for improving dysphagia |
| JPWO2014199486A1 (ja) * | 2013-06-13 | 2017-02-23 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 嚥下障害改善用医薬品 |
| CA2923270A1 (en) * | 2013-09-03 | 2015-03-12 | Shin Nippon Biomedical Laboratories Ltd. (Snbl) | Intranasal formulation for the treatment of cardiopulmonary resuscitation (cpr), cardiac life support (cls), anaphylaxis and/or anaphylactoid reactions |
| EP4008307A1 (en) * | 2013-09-24 | 2022-06-08 | Satsuma Pharmaceuticals, Inc. | Intranasal dhe formulation for the treatment of headache |
| WO2015095644A1 (en) | 2013-12-20 | 2015-06-25 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
| JPWO2016163403A1 (ja) * | 2015-04-07 | 2018-02-01 | ニプロ株式会社 | 経口フィルム製剤 |
| EP3341059B1 (en) | 2015-09-10 | 2022-03-02 | Impel NeuroPharma Inc. | In-line nasal delivery device |
| CN110996912A (zh) | 2017-08-20 | 2020-04-10 | 福摩莱克斯医药创新有限公司 | 用于鼻内递送的干粉组合物 |
| US11844859B2 (en) | 2017-08-20 | 2023-12-19 | Nasus Pharma Ltd. | Dry powder compositions for intranasal delivery |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| WO2019059953A2 (en) | 2017-09-22 | 2019-03-28 | Otitopic Inc. | DRY POWDER COMPOSITIONS CONTAINING MAGNESIUM STEARATE |
| US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices |
| JP2021503988A (ja) | 2017-11-21 | 2021-02-15 | インペル ニューロファーマ インコーポレイテッド | インレットインターフェースを用いた鼻腔内装置 |
| WO2019104205A1 (en) | 2017-11-21 | 2019-05-31 | Impel Neuropharma, Inc. | Intranasal device with dip tube |
| MX2020005437A (es) | 2017-11-27 | 2020-08-27 | Aska Pharm Co Ltd | Preparacion en polvo para administracion nasal. |
| CN111936140A (zh) | 2018-01-05 | 2020-11-13 | 英倍尔药业股份有限公司 | 通过精密鼻装置的双氢麦角胺的鼻内递送 |
| CN111836615A (zh) | 2018-01-05 | 2020-10-27 | 英倍尔药业股份有限公司 | 通过精密鼻装置的奥氮平的鼻内递送 |
| WO2019182745A1 (en) | 2018-03-19 | 2019-09-26 | Bryn Pharma, LLC | Epinephrine spray formulations |
| WO2019199704A1 (en) | 2018-04-09 | 2019-10-17 | Katana Pharmaceuticals, Inc. | Oxytocin compositions and methods of use |
| WO2020018959A1 (en) | 2018-07-19 | 2020-01-23 | Impel Neuropharma, Inc. | Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease |
| US10758532B2 (en) | 2018-12-11 | 2020-09-01 | Satsuma Pharmaceuticals, Inc. | Compositions, devices, and methods for treating or preventing headaches |
| MX2021008082A (es) | 2019-01-03 | 2021-08-05 | Impel Pharmaceuticals Inc | Dispositivo de administracion de farmaco nasal. |
| CN113784703A (zh) * | 2019-05-16 | 2021-12-10 | 株式会社新日本科学 | 经鼻施予用粉末制剂及其制造方法 |
| BR112021023049A8 (pt) | 2019-05-17 | 2022-10-18 | Impel Neuropharma Inc | Dispositivo de dispensação nasal de uso único |
| EP4090331A4 (en) * | 2020-01-14 | 2023-12-27 | Impel Pharmaceuticals Inc. | REPEATED ADMINISTRATION OF DIHYDROERGOTAMINE FOR THE TREATMENT OF FREQUENT MIGRAINOUS HEADHEAVES |
| US20210283074A1 (en) * | 2020-03-16 | 2021-09-16 | Nasus Pharma Ltd. | Polymeric Compositions for Intranasal Administration |
| WO2022132018A1 (en) * | 2020-12-16 | 2022-06-23 | Liw Innovation Ab | A new powder composition |
| WO2025220834A1 (ko) * | 2024-04-16 | 2025-10-23 | 한미약품 주식회사 | 흡입제 조성물 |
Family Cites Families (128)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2224175B1 (cg-RX-API-DMAC7.html) | 1973-04-04 | 1978-04-14 | Isf Spa | |
| IT1017153B (it) | 1974-07-15 | 1977-07-20 | Isf Spa | Apparecchio per inalazioni |
| JPS53127553A (en) | 1977-04-13 | 1978-11-07 | Asahi Chem Ind Co Ltd | Vehicle |
| JPS5420126A (en) | 1977-07-12 | 1979-02-15 | Asahi Chem Ind Co Ltd | Pharmaceutical composition |
| AU508480B2 (en) | 1977-04-13 | 1980-03-20 | Asahi Kasei Kogyo Kabushiki Kaisha | Microcrystalline cellulose excipient and pharmaceutical composition containing thesame |
| JPS5462328A (en) | 1977-10-24 | 1979-05-19 | Asahi Chem Ind Co Ltd | Additive for cosmetics |
| US4226233A (en) | 1978-10-10 | 1980-10-07 | Longevity Products, Inc. | Respirators |
| US4300545A (en) | 1980-06-23 | 1981-11-17 | Schering Corporation | Method and nozzle for nasal vaccination of immature mammals |
| JPS5934267A (ja) | 1982-08-23 | 1984-02-24 | 帝人株式会社 | 粉状薬剤施薬装置 |
| JPS59163313A (ja) | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| DE3345722A1 (de) | 1983-12-17 | 1985-06-27 | Boehringer Ingelheim KG, 6507 Ingelheim | Inhalator |
| JPS60224616A (ja) | 1984-04-24 | 1985-11-09 | Teijin Ltd | 経鼻投与用組成物 |
| JPS6242888A (ja) | 1985-08-21 | 1987-02-24 | カシオ計算機株式会社 | 太陽電池を備えたｉｃカ−ド |
| US5731303A (en) | 1985-12-04 | 1998-03-24 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery compositions |
| JPS63267731A (ja) | 1987-04-23 | 1988-11-04 | Asahi Chem Ind Co Ltd | 錠剤組成物 |
| JPS6475800A (en) | 1987-09-16 | 1989-03-22 | Mitsui Constr | Concrete spraying device |
| ATE99543T1 (de) | 1987-10-15 | 1994-01-15 | Syntex Inc | Pulverfoermige zubereitungen zur intranasalen verabreichung von polypeptiden. |
| JPH02196719A (ja) | 1989-01-24 | 1990-08-03 | Green Cross Corp:The | 粉末状医薬組成物 |
| US4947097A (en) | 1989-06-12 | 1990-08-07 | The Grass Valley Group, Inc. | Automatic switching of motion control with tactile feedback |
| DK198591D0 (da) | 1991-12-10 | 1991-12-10 | Novo Nordisk As | Apparat |
| US5320094A (en) | 1992-01-10 | 1994-06-14 | The Johns Hopkins University | Method of administering insulin |
| GB2269992A (en) | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
| US5417984A (en) | 1992-12-14 | 1995-05-23 | Biocontrol, Inc. | Low crystallinity cellulose excipients |
| AU6167894A (en) | 1993-01-29 | 1994-08-15 | Miris Medical Corporation | Intrapulmonary delivery of hormones |
| US5672581A (en) | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
| ES2194867T3 (es) | 1993-03-26 | 2003-12-01 | Franciscus Wilhelmus He Merkus | Composiciones farmaceuticas para la administracion intranasal de apomorfina. |
| JPH07165613A (ja) | 1993-10-19 | 1995-06-27 | Dot:Kk | 経鼻吸収薬物用キャリヤおよび生理活性ペプチド組成物 |
| SE9303574D0 (sv) | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Composition for drug delivery and method the manufacturing thereof |
| US5958458A (en) | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
| DE69510894T2 (de) | 1994-06-16 | 2000-02-03 | Pharmacia & Upjohn S.P.A., Mailand | Verfahren zur Herstellung mucoadhesiver Stärke |
| JPH0898888A (ja) | 1994-09-30 | 1996-04-16 | Teijin Ltd | 粉末状薬剤噴霧施薬装置 |
| JP3308419B2 (ja) | 1995-02-06 | 2002-07-29 | 株式会社ユニシアジェックス | 鼻腔用投薬器 |
| JP3308425B2 (ja) | 1995-03-10 | 2002-07-29 | 株式会社ユニシアジェックス | 鼻腔用投薬器 |
| JPH08243164A (ja) | 1995-03-13 | 1996-09-24 | Unisia Jecs Corp | 鼻腔用投薬器 |
| JP3320261B2 (ja) | 1995-06-01 | 2002-09-03 | 株式会社ユニシアジェックス | 吸入式投薬器 |
| JP3098401B2 (ja) * | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
| JP3317827B2 (ja) | 1995-10-09 | 2002-08-26 | 株式会社ユニシアジェックス | 投薬器 |
| JP3197221B2 (ja) | 1996-02-27 | 2001-08-13 | 帝人株式会社 | 吸収性が改善された粉末状経鼻投与組成物 |
| KR100568436B1 (ko) | 1996-02-27 | 2007-04-25 | 데이진 가부시키가이샤 | 분말상경비투여조성물 |
| JP3197223B2 (ja) | 1996-02-28 | 2001-08-13 | 帝人株式会社 | 即効性と持続性を兼ね備えた粉末状経鼻投与用組成物 |
| JPH09253208A (ja) | 1996-03-21 | 1997-09-30 | Unisia Jecs Corp | 鼻腔用投薬器 |
| JPH09276405A (ja) | 1996-04-15 | 1997-10-28 | Unisia Jecs Corp | 鼻腔用投薬器 |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| JP3020141B2 (ja) * | 1996-10-07 | 2000-03-15 | 株式会社富士薬品 | 経鼻投与用製剤 |
| GB9700624D0 (en) | 1997-01-14 | 1997-03-05 | Danbiosyst Uk | Drug delivery composition |
| DE69839356T2 (de) | 1997-01-30 | 2009-06-25 | Dott Ltd. Co., Yokohama | Trockenpulverinhalator für Kapseln |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| JP2001517692A (ja) | 1997-09-29 | 2001-10-09 | インヘール セラピューティック システムズ， インコーポレイテッド | ネブライザにおける使用のための安定化調製物 |
| EP1020193A4 (en) * | 1997-09-30 | 2006-05-24 | Daiichi Seiyaku Co | ORAL PREPARATION |
| FR2771012B1 (fr) | 1997-11-17 | 2000-03-10 | Sofab | Pulverisateur nasal |
| JPH11216357A (ja) | 1998-02-03 | 1999-08-10 | Tsutsumi Techno Planning Kk | 生理活性物質用の吸着担体 |
| JP3530004B2 (ja) | 1998-02-06 | 2004-05-24 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
| GB9807232D0 (en) | 1998-04-03 | 1998-06-03 | Univ Cardiff | Aerosol composition |
| JPH11322582A (ja) | 1998-05-06 | 1999-11-24 | Dot:Kk | 経鼻吸収用鼻粘膜付着・滞留型キャリヤ |
| GT199900061A (es) * | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
| AU755616B2 (en) | 1998-06-05 | 2002-12-19 | Warner-Lambert Company | Stabilization of compositions containing ace inhibitors using magnesium oxide |
| TWI223598B (en) | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
| CA2307607C (en) | 1998-08-26 | 2008-02-05 | Teijin Limited | Powdery nasal compositions |
| CA2341732C (en) | 1998-08-26 | 2008-08-19 | Teijin Limited | Powder composition for nasal administration |
| DE69934435T2 (de) | 1998-10-20 | 2007-09-27 | University Of North Carolina At Chapel Hill | Methoden zum befeuchten der nasenschleimhaut |
| GB9828721D0 (en) | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
| JP2000229859A (ja) | 1999-02-12 | 2000-08-22 | Teijin Ltd | 安定なブプレノルフィン経鼻製剤 |
| JP2000239187A (ja) | 1999-02-22 | 2000-09-05 | Dotto:Kk | 経鼻吸収用組成物 |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| JP3912469B2 (ja) | 1999-05-13 | 2007-05-09 | セイコーエプソン株式会社 | 偽造印刷物判定用インク |
| JP2001055323A (ja) | 1999-08-12 | 2001-02-27 | Teijin Ltd | 粉末状経鼻投与用組成物 |
| US6197328B1 (en) | 1999-08-20 | 2001-03-06 | Dott Research Laboratory | Nasally administrable compositions |
| US7022311B1 (en) | 1999-10-12 | 2006-04-04 | Kaken Pharmaceutical Co., Ltd. | Powdery inhalational preparations and process for producing the same |
| DE10049392A1 (de) | 1999-10-14 | 2001-04-19 | Becton Dickinson Co | Flüssigkeits-Ausgabevorrichtung |
| GB9925934D0 (en) | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
| ATE267582T1 (de) | 2000-01-20 | 2004-06-15 | Basilea Pharmaceutica Ag | Nasal verabreichbare cyclische antimykotische peptidzusammensetzungen |
| BR0106729B1 (pt) | 2000-06-12 | 2009-08-11 | dispositivo de administração de multiplas doses de medicamento em pó. | |
| DE10031043A1 (de) * | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
| EP1328260A2 (en) | 2000-10-18 | 2003-07-23 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
| JP2002161030A (ja) * | 2000-11-27 | 2002-06-04 | Unisia Jecs Corp | 異なる粒径をもった混合粉体の吸入方法 |
| US6595210B2 (en) | 2000-11-27 | 2003-07-22 | Unisia Jecs Corporation | Inhalator for administering powder composition |
| JP2002255795A (ja) | 2001-02-26 | 2002-09-11 | Teijin Ltd | 経鼻投与用組成物 |
| WO2002094233A1 (en) | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of antiemetics through an inhalation route |
| CN100341567C (zh) | 2001-07-05 | 2007-10-10 | 产业化研究株式会社 | 胰岛素的经鼻给药用组合物 |
| WO2003024396A2 (en) * | 2001-09-17 | 2003-03-27 | Glaxo Group Limited | Dry powder medicament formulations |
| DK1443912T3 (da) | 2001-10-12 | 2008-01-21 | Elan Pharma Int Ltd | Sammensætninger med en kombination af umiddelbare og kontrollerede frisætningsegenskaber |
| JP3975327B2 (ja) | 2001-11-19 | 2007-09-12 | 株式会社 バイオアクティス | 鼻腔用粉状薬剤施薬装置 |
| US20040092428A1 (en) | 2001-11-27 | 2004-05-13 | Hongming Chen | Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof |
| JP2003175103A (ja) | 2001-12-12 | 2003-06-24 | Teijin Ltd | 粉末薬剤多回投与器 |
| FR2834212B1 (fr) | 2001-12-27 | 2004-07-09 | Besins Int Belgique | Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques |
| JP4212019B2 (ja) | 2002-01-09 | 2009-01-21 | Ｔｒａｎｓｌａｔｉｏｎａｌ Ｒｅｓｅａｒｃｈ 株式会社 | 薬物の経鼻投与用組成物 |
| WO2003077825A2 (en) | 2002-03-12 | 2003-09-25 | Microdose Technologies, Inc. | Site specific delivery of co-administered drugs via inhalation |
| WO2003077912A1 (en) | 2002-03-20 | 2003-09-25 | The University Of Queensland | Method of treatment and/or prophylaxis |
| JP3950738B2 (ja) | 2002-05-14 | 2007-08-01 | 株式会社 バイオアクティス | 鼻腔用粉状薬剤施薬装置 |
| LT1531794T (lt) | 2002-06-28 | 2017-08-25 | Civitas Therapeutics, Inc. | Inhaliuojamas epinefrinas |
| AU2003249105A1 (en) * | 2002-07-08 | 2004-01-23 | Ranbaxy Laboratories Limited | Processes for the preparation of oral dosage formulations of modafinil |
| GB0215904D0 (en) | 2002-07-09 | 2002-08-21 | Team Holdings Uk Ltd | Drug delivery system and method |
| US6855913B2 (en) | 2002-08-06 | 2005-02-15 | Hobart Brothers Company | Flux-cored wire formulation for welding |
| CN1176649C (zh) * | 2002-10-16 | 2004-11-24 | 上海医药工业研究院 | 舒马普坦干粉吸入剂及其制备方法 |
| GB2395900A (en) | 2002-12-04 | 2004-06-09 | Elan Drug Delivery Ltd | Therapeutic composition for respiratory delivery |
| GB0228826D0 (en) | 2002-12-11 | 2003-01-15 | Okpala Joseph | Hair technology in creating particles with improved delivery capabilities |
| US20040173211A1 (en) | 2003-01-14 | 2004-09-09 | Boehringer Ingelheim International Gmbh | Powder inhaler |
| MXPA05008140A (es) | 2003-01-31 | 2005-09-30 | Orexo Ab | Una composicion farmaceutica de rapida accion. |
| WO2004073729A1 (ja) | 2003-02-21 | 2004-09-02 | Translational Research Ltd. | 薬物の経鼻投与用組成物 |
| JP4136724B2 (ja) | 2003-03-05 | 2008-08-20 | 株式会社日立製作所 | 鼻腔用投薬器 |
| US20060116657A1 (en) | 2003-03-21 | 2006-06-01 | Daniel Schmid | Mixing capsule |
| US7278982B2 (en) | 2003-03-27 | 2007-10-09 | Bioactis Limited | Powder medicine applicator for nasal cavity |
| KR20060015641A (ko) * | 2003-06-06 | 2006-02-17 | 글락소 그룹 리미티드 | 트립탄 및 ｎｓａｉｄ를 포함하는 조성물 |
| US7954491B2 (en) | 2003-06-13 | 2011-06-07 | Civitas Therapeutics, Inc. | Low dose pharmaceutical powders for inhalations |
| US20050042177A1 (en) | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
| CA2540204A1 (en) | 2003-10-09 | 2005-04-21 | Bioactis Limited | Device to deliver powdery medicine into nasal cavity |
| GB0328186D0 (en) * | 2003-12-05 | 2004-01-07 | West Pharm Serv Drug Res Ltd | Intranasal compositions |
| US8545881B2 (en) * | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
| PT2708225T (pt) | 2004-04-23 | 2019-05-21 | Cydex Pharmaceuticals Inc | Formulação de dpi contendo éter sulfoalquílicociclodextrina |
| EP1785145A4 (en) | 2004-08-10 | 2008-08-13 | Translational Res Ltd | TRANSNASAL COMPOSITION WITH IMMEDIATE EFFECT AND HIGH RESORBIBILITY |
| EA200700743A1 (ru) | 2004-10-06 | 2007-10-26 | Бёрингер Ингельхайм Интернациональ Гмбх | Устройство для распыления порошка, устройство для хранения порошка и способ распыления порошка |
| EP1802276A1 (en) | 2004-10-15 | 2007-07-04 | Pfizer Products Inc. | Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
| GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| CA2617909C (en) | 2005-08-05 | 2014-02-04 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
| US20070055200A1 (en) | 2005-08-10 | 2007-03-08 | Gilbert Scott J | Needle-free jet injection drug delivery device |
| JP2008518041A (ja) * | 2005-08-29 | 2008-05-29 | テバ ファーマシューティカル インダストリーズ リミティド | 双峰性粒度分布を有する固体微粒子タダラフィル |
| JP2008538783A (ja) | 2006-01-31 | 2008-11-06 | テバ ファーマシューティカル インダストリーズ リミティド | ブロード且つ多峰性の粒度分布を有するオキシカルバゼピンを含む医薬製剤及びその調製方法 |
| TW200811104A (en) * | 2006-04-25 | 2008-03-01 | Theravance Inc | Crystalline forms of a dimethylphenyl compound |
| US7806117B2 (en) | 2006-06-07 | 2010-10-05 | Shin Nippon Biomedical Laboratories, Ltd. | Peroral powder delivery device |
| JP2009544715A (ja) * | 2006-07-28 | 2009-12-17 | ノヴァデル ファーマ インコーポレイテッド | 抗片頭痛の口腔噴霧製剤及び方法 |
| US20080029084A1 (en) * | 2006-08-04 | 2008-02-07 | Nastech Pharmaceutical Company Inc. | Device for improved peptide delivery |
| AU2007294547A1 (en) | 2006-09-07 | 2008-03-13 | Parion Sciences, Inc. | Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| GB0625322D0 (en) * | 2006-12-19 | 2007-01-24 | Pharmakodex Ltd | Pharmaceutical compositions |
| JP5415769B2 (ja) | 2006-12-26 | 2014-02-12 | 株式会社新日本科学 | 経鼻投与用製剤 |
| GB2448183A (en) * | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
| CA2702261A1 (en) | 2007-10-12 | 2009-04-16 | Map Pharmaceuticals, Inc. | Inhalation drug delivery |
| CA2728808A1 (en) * | 2008-02-01 | 2009-08-06 | Vectura Limited | Pulmonary formulations of triptans |
| WO2011013003A2 (en) | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
-
2010
- 2010-05-14 JP JP2011548484A patent/JP2012526726A/ja active Pending
- 2010-05-14 EP EP10774745.3A patent/EP2429495A4/en not_active Withdrawn
- 2010-05-14 WO PCT/JP2010/003285 patent/WO2010131486A1/en not_active Ceased
- 2010-05-14 US US12/780,433 patent/US9101539B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012526726A5 (cg-RX-API-DMAC7.html) | ||
| JP7042015B2 (ja) | 経口投与型コルチコステロイド組成物 | |
| JP6043281B2 (ja) | ４−アミノ−５−フルオロ−３−［６−（４−メチルピペラジン−１−イル）−１ｈ−ベンズイミダゾール−２−イル］−１ｈ−キノリン−２−オンラクテート一水和物を含む医薬組成物 | |
| EP1945186B1 (en) | Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent | |
| ES2543108T3 (es) | Preparación sólida fácilmente administrable | |
| EP1787640A1 (en) | Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition | |
| AU2012250862B2 (en) | Rapid dissolve tablet compositions for vaginal administration | |
| JPWO2011118453A1 (ja) | 固形製剤 | |
| WO2010110322A1 (ja) | 固形製剤 | |
| WO2009034540A1 (en) | Pharmaceutical composition of sevelamer | |
| JPWO2010110320A1 (ja) | 固形製剤 | |
| JP2017523149A (ja) | エドキサバンの医薬組成物 | |
| JP2013531059A (ja) | マルチユニット錠剤組成物 | |
| JP2018509473A (ja) | ポリマーの水溶液 | |
| RU2709526C2 (ru) | Фармацевтические композиции, которые содержат лобеглитазон, для перорального введения | |
| CN106999436B (zh) | 含有分娩控制物质的口服崩解固体药物剂量单元 | |
| CN107106640B (zh) | 含有分娩控制物质的口服崩解固体药物剂量单元 | |
| JP6186139B2 (ja) | 口腔内速崩壊性錠剤 | |
| CN105596304B (zh) | 用于减缓周边血管疾病病患间歇性跛行症状的属喹啉酮衍生物的西洛他唑的新颖调配物 | |
| JP2016098230A5 (cg-RX-API-DMAC7.html) | ||
| JP2010059152A (ja) | モノステアリン酸グリセリンを含有するエナラプリルマレイン酸塩錠剤 | |
| HK1126394B (en) | Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent | |
| JP2012012414A (ja) | 錠剤、およびその製造方法 | |
| AU2014233629A1 (en) | Orally administered corticosteroid compositions | |
| HK1235301A1 (en) | Pharmaceutical compositions comprising lobeglitazone for oral administration |